A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 13, 2023

Primary Completion Date

July 4, 2024

Study Completion Date

July 4, 2024

Conditions

Healthy Volunteers - Liver Diseases

Interventions

DRUG

NNC0560-0004

NNC0560-0004, Oral administration (taken through the mouth)

DRUG

Placebo (NNC0560-0004)

Placebo matching NNC0560-0004, Oral administration (taken through the mouth)

Trial Locations (1)

Northwick Park Hosptial, Watford